Hematology

Trials, guidelines and clinical evidence across Hematology.

Multiple Myeloma Fiscal Burden in Croatia Rose to €44.99 Million

Croatia’s multiple myeloma burden climbed sharply from 2009 to 2024, driven by rising treatment costs and growing productivity losses.

A phase I/II transplant study found fresh purified donor Tregs were feasible and linked to less GVHD with…

MHRA extends Casgevy to children aged five and over with severe sickle-cell disease and transfusion-dependent beta-thalassemia in the…

An inquest heard that Veronique Mwembo’s sickle cell pain was dismissed in hospital, raising concerns about emergency care…

CIBMTR analysis links race, ethnicity, and income to graft-versus-host disease outcomes after allo-HCT, with severe aGVHD driving excess…

A single-center study found acute kidney injury after CD19 CAR T therapy in 10% of NHL patients, with…

Jehovah’s Witnesses may now decide on blood components as a matter of conscience, while refusal of whole blood…

Pilot case-control study found no buccal mucosal cytomorphological abnormalities in treated Sudanese children with sickle cell anaemia versus…

A narrative review links gut dysbiosis to leukemia, lymphoma, and myeloma biology, with emerging microbiota-based biomarkers and therapies.

Venetoclax with azacitidine, decitabine, or low-dose cytarabine has changed frontline AML care for older patients ineligible for intensive…

Hematology

Trials, guidelines and clinical evidence across Hematology.

In Brief The 5-minute rounds